About James Latorre
James Latorre is a director at Lytica Therapeutics.
James Latorre first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name James Latorre in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Latorre works with at each company, as listed on that company's latest Form D.
Lytica Therapeutics, Inc. · Form D, Apr 11, 2025